| Authors: |
Linglart A; AP-HP, Endocrinology and Diabetes for Children, Reference Center for Rare Disorders of the Calcium and Phosphate Metabolism, and Filière OSCAR, Bicêtre Paris Saclay Hospital, Le Kremlin-Bicêtre, France.; Paris-Saclay University, INSERM 1189, Le Kremlin-Bicêtre, France., Imel EA; Indiana University School of Medicine, Indianapolis, IN, USA., Whyte MP; Shriners Hospitals for Children - St. Louis, MO, USA.; Division of Bone and Mineral Diseases, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA., Portale AA; University of California, San Francisco, CA, USA., Högler W; Johannes Kepler University Linz, Linz, Austria.; University of Birmingham, Birmingham, UK., Boot AM; University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Padidela R; Royal Manchester Children's Hospital and Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Van't Hoff W; Great Ormond Street Hospital, London, UK., Gottesman GS; Shriners Hospitals for Children - St. Louis, St Louis, MO, USA., Chen A; Ultragenyx Pharmaceutical Inc., Novato, CA, USA., Skrinar A; Ultragenyx Pharmaceutical Inc., Novato, CA, USA., Scott Roberts M; Ultragenyx Pharmaceutical Inc., Novato, CA, USA., Carpenter TO; Yale University School of Medicine, New Haven, CT, USA. |
